SOME PECULIARITIES OF SCHIZOPHRENIA-RELATED MENTAL DISEASES ETIOLOGICAL STRUCTURE

Список литературы: List of references 1. Abramov V.A. Personality-oriented psychiatry: value-humanist approaches/ V.A. Abramov, O.I. Osokina, G.G. Putiatin. - Donetsk: Kashtan, 2014. - 296 p. 2. Baiano, M., David, A., Versace, A. [et al.] Anterior cingulated volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies // Schizophrenia Researches. - 2007. - P. 1–12. 3. Balashov A.M. Prospects of Genetics and Pharmacogenetics in Psychiatry/ A.M. Balashov // Psychiatry and Psychopharmacotherapy. - 2006. - V. 8. - p. 4-10. 4.Belluck P., Carey B. Psychiatry`s guide is out of touch with science, experts say // New York Times. - 2013. - №5. - P. 25-29. 5. E. Berne Games People Play: The Psychology of Human Relationships. Games People Play: The Psychology of Human Destiny. / E. Bern - M.: Progress, 1988. - 400 p. 6. Burns J., Job D., Bastin M.E., Whalley H., Macgillivray T., Johnstone E.C., [et al.] Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study // British Journal of Psychiatry. 2003. - №12. - P.35-39. 7. C. Gaser, I. Nenadic, H.-P. Volz1, C. Büchel and H. Sauer Neuroanatomy of ‘Hearing Voices’: A Frontotemporal Brain Structural Abnormality Associated with Auditory Hallucinations in Schizophrenia // Cerebral Cortex. 2004. - №14. - Р. 91- 96. 8. Csernansky J. [et al.] Abnormalities of thalamic volume and shape in schizophrenia // Am J. Psychiatry. 2004. №161. - Р. 896-902. 9. Davis J. M. A Meta-analysis of the Efficacy of Second-Generation Antipsychotics / J. M. Davis, N. Chan, I. D. Glick. // Archives of General Psychiatry. – 2003. – V. 60, № 6. – P. 553-564. 10. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. (DSM-5). American Psychiatric Association. - Washington DC. - 2013. 11. Dobrokhotova T.A. Neuropsychiatry / T.A. Dobrokhotova - M.: BINOM. - 2006 - 304 p. 12. Gorobets L.N. Neuroendocrine dysfunctions and neuroleptic therapy / L.N. Gorobets - M.: PH "MEDPRAKTIKA-M", 2007 - 312 p. 13. Harvey Ph. [et al] Negative symptoms and cognitive defects: what is the nature of their relationship // Schіzophrenia Bulletin. - 2006. - V. 32. - P. 250-258. 14. Heike Tost, Tajvar Alam, Andreas Meyer- Lindenberg Dopamine and Psychosis: Theory, Pathomechanisms and Intermediate Phenotypes // Neuroscience. - 2010. - №5. - Р. 689–700. 15. Howes D. O. The dopamine hypothesis of schizophrenia: version III—the final common pathway / D. O. Howes, S. Kapur. // Schizophrenia Bulletin. – 2009. – V. 35, № 3. – P. 549-562. 16. Javitt D.C. Glutamate as a therapeutic target in psychiatric disorders / D. C. Javitt. // Molecular Psychiatry. – 2004. – V. 9, № 11. – P. 984-997. 17. Kaplan G. B. Brain circuitry and signaling in psychiatry./ G. B. Kaplan, R. P.Hammer jr.. – Washington, DC.: American Psychiatric Publishing Inc., 2002. – 266 p. 18. Kapur S. Dopamine in patophysiology and treatment of schizophrenia / S. Kapur, Y. Lecrubier. - L.: Martin Dunitz, Taylor&Francis Group. - 2005. - 232 p. 19. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research. - 2005. - V. 79. - P. 59–68. 20. Kubicki M, Westin CF, Maier SE, Frumin M, Nestor PG, Salisbury DF [et al.] Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study // American Journal of Psychiatry. - 2002. - V. 159, №5. - Р. 813–820. 21. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies / Laruelle M. // Brain Research Reviews. - 2000. - V. 31, № 1-2. - P. 371-384. 22. Lawrie S., McIntosh A. Schizophrenia (Part 2). / Lawrie S., McIntosh A. - M.: Media Sfera. - 2003. - p. 971-1001. 23. Lewis D. A. Cortical inhibitory neurons and schizophrenia / D. A. Lewis, T. Hashimoto, D. W.Volk. // Nature Reviews Neuroscience. - 2005. - V. 6. - P. 312-324. 24. Lieberman J. A. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia / J. A. Lieberman, T. S. Stroup, J. P. McEvoy et al. // New England Journal of Medicine. - 2005. - V. 353, № 12. - P. 1209-1223. 25. Lieberman J. A. Provocative tests with psychostimulant drugs in schizophrenia / J. A. Lieberman, J. M. Cane, J. Alvir. // Psychopharmacology. - 1987. - V. 91, № 4. - P. 415- 433. 26. Lisman J. A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia / J. E. Lisman, J. T. Coyle, R. W. Green et al. // Trends in Neuroscience. - 2008. - V. 31, № 5. - Р. 234-242. 27. Maj M. The DSM-5 approach to psychotic disorders. Is it possible to overcome the «inherent conservative bias»? // Schizophrenia Researches. - 2013. - №10. - Р. 132-138. 28. Manschreck T. C. The CATIE schizophrenia trial: results, impact, controversy / T. C. Manschreck, R. A. Boshes. // Harvard Review of Psychiatry. - 2007. - V. 15, № 5. - P. 245-258. 29. Marek Kubicki, Robert McCarley, Carl- Fredrik Westin, Hae-Jeong Park, Stephan Maier, Ron Kikinis,b Ferenc A. Jolesz, and Martha E. Shentona. A review of diffusion tensor imaging studies in schizophrenia // Psychiatric Researches. - 2007. V. 41. - P. 15–30. 30. Möller H-J. Development of DSM-V and ICD- 11: Tendencies and potential of new classifications in psychiatry at the current state of knowledge // Psychiatry Clinic Neuroscience. - 2009. - №63. - P. 595–612. 31. Morbidity rate of mental disorders and activities of psychiatric institutions in Ukraine in 2011 - K.: Ministry of Public Health of Ukraine, SI "Center of Medical Statistics", 2012. 32. Nesvag, R., Lawyer, G., Varnas, K., et al., 2008. Regional thinning of cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication // Schizophrenia Reserches. - V.98. - P. 16–28. 33. Palaniyappana L., Guo S., Liddlea P. F. and Fenga J., 2016. Dynamic cerebral reorganization in the pathophysiology of schizophrenia: a MRI-derived cortical thickness study // Psychological Medicine. - 2016. - №1. - 14 p. 34. Pedak A.A. Neuro-psychiatric and clinical- psychophysiological aspects of the interhemispheric asymmetry in schizophrenia in the process of lateral electro-analgesia of the brain // Materials of the scientific-practical conference with the participation of international specialists: "Current issues of modern psychiatry, narcology and neurology" / According to the general editorship of the prof. V. Sh. Ponomarev. - Kharkiv, 2014. - p. 85-88. 35. Pedak A.A. Summary-directed psychopharmacological effect or polypragmasy - the basis of the current approach to the mental disorder therapy: Materials of the scientific-practical conference with international participation "Integration of psychiatry, psychotherapy and psychology into modern medicine", June 6-7, 2013, Gaspra, Crimea // Tavria Pscychiatric Magazine. - V. 17 - No. 2 (63). - 2013. - p. 60. 36. Scherk, H., Falkai, P. Effects of antipsychotics on brain structure // Psychiatry. - 2006. - №19. - P. 145– 150. 37. Schizophrenia Working Group of the Psychiatric Genomics Consortium / Biological insights from 108 schizophrenia-associated genetic loci // Nature. 2014. - № 5. - Р. 421–427. 38. Schmitt A., Weber-Fahr W., Jatzko A., Tost H., Henn F.A., Braus D.F. Current overview of structural magnetic resonance imaging in schizophrenia // Fortschritte der Neurologie- Psychiatrie. - 2001. - V. 69, №3. - P. 105-115. 39. Shmukler A.B. Modern Approaches to the Diagnostics of Schizophrenia and Schizophrenia- Related Disorders (DSM-5 Concept) // P.B. Gannushkina Psychiatry and Psychopharmacotherapy. - 2013. - No. 05. - p. 10-15. 40. Smulevich A.B. Schizophrenia or a group of endogenous diseases? History and Modernity. / A.B. Smulevich // S. S. Korsakov Magazine of Neurology and Psychiatry. - 2015. - No. 8. - p. 4-12. 41. Spollen J. J. Neurobiology of schizophrenia. [electronic resource] / J. J. Spollen. // MedscapeCME. - 2002. – Access mode : http://cme.medscape.com/viewarticle/436396. 42. Stain D. J. Evidence-based psychopharmacology / D. J. Stain, B. Lerer, S. Stahl. – N.Y.: Cambridge University Press. - 2005. – 362 p. 43. Stahl S. M. Stahl‘s essential psychopharmacology: neuroscientific basis and practical applications. 3-rd edition / S.M. Stahl. – NY.: Cambridge University Press. - 2008. – 1117 p. 44. Stöber G. Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers / G. Stöber, D. Ben- Shachar, M. Cardon et al. // The World Journal of Biological Psychiatry. – 2009. – V. 10, № 2. – P. 127- 155. 45. Tandon R. Schizophrenia and other psychotic disorders in DSM-5: Clinical implications of revisions from DSM-IV // Clinical Schizophrenia Related Psychoses. - 2013. - №3. - P. 16–19. 46. Tzschentke T. M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system / T. M. Tzschentke. // Progress in Neurobiology. – 2001. – V. 63, № 3. – P. 241-320. 47. Vita, A., De Peri, L., Silenzi, C. [et al.] Brain morphology in firstepisode schizophrenia: a meta- analysis of quantitative magnetic resonance imaging studies // Schizophrenia Researches. - 2006. - V. 82. - P. 75–88. 48. Walter Henrik. Functional visualization in psychiatry and psychotherapy / Walter Henrik - M.: AST: Astrel: Poligrafiztat. - 2010 – p. 416 49. Weinberger, D.R., McClure, R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? // Psychiatry. - 2002. - №59. - P. 553–558.